United States · Startup
United States · Kalidex Pharmaceuticals, Inc.
Kalidex manufactures pharmaceuticals, develops novel fluoroquinolone antibiotic.
Funding reportedLast round: Series A
Follow Kalidex Pharmaceuticals, Inc. and see its new rounds in your feed.Start following
What company datasets say Kalidex Pharmaceuticals, Inc. raised
Funding, as reported
Reported in all$45Min dollars
Last roundSeries A
Last round size$45M
Last round dateFeb 2011
Founders and team
From the SEC filings it signed: 2 on the team.
- Chun (Vernon) JiangExecutive Officeri
- Yigong (James) GeExecutive Officer, Directori
On the board, as filediBrent (Vernon) AhrensDennis (Vernon) PodlesakGary (Vernon) PatouPatrick (Vernon) HeronRon (Vernon) HuntShelley (Vernon) Chu
Is this your company?
Add your raise, your deck and your story, and put Kalidex Pharmaceuticals, Inc. in front of investors. Or tell us what we have wrong.